Skip to main content

Table 2 Association of PDCD6 mRNA expression with clinical and pathological characteristics of ovarian cancer

From: PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer

  

PDCD6 Expression

Variable

n

Median (5th-95th)a

p- valueb

Lowc

Middled

Highe

p- valuef

Stage

211

  

n (%)

n (%)

n (%)

 

   I-II

63

0.16 (0-4.78)

0.183

25(39.7)

28(44.4)

10(15.9)

0.256

   III-IV

148

0.28 (0-5.26)

 

52(35.1)

57(38.5)

85(26.4)

 

Grade

211

      

   1~2

73

0.16 (0-4.41)

0.275

26(35.6)

33(45.2)

14(19.2)

0.477

   3

138

0.29 (0-5.53)

 

51(37.0)

52(37.7)

35(25.4)

 

Histology

212

      

   Non-Serous

127

0.20 (0-5.03)

0.321

47(37.0)

53(41.7)

27(21.3)

0.734

   Serous

85

0.28 (0-5.41)

 

30(35.3)

33(38.8)

22(25.9)

 

Residual Tumor

206

      

   No Residual

90

0.18 (0-3.69)

0.261

32(35.6)

43(47.8)

15(16.7)

0.050 h

   Residual

116

0.31 (0-7.20)

 

43(37.1)

39(33.6)

34(29.3)

 
  1. a Expression levels at the 5th and 95th percentiles;b Wilcoxon two-sample test with t approximation;c Low: Expression Index (EI) < 0.1;
  2. d Middle: Expression Index (EI) 0.1-1;e High: Expression Index (EI) > 1;f p- value from Chi-square test;
  3. g p- value from Spearman correlation test;h Bold values are statistically significant (p < 0.05)